Associate Professor Nick West
Associate Professor

Nick West

Email: 
Phone: 
+61 7 336 54093

Background

Associate Professor West is a molecular microbiologist, expert in bacterial pathogenesis. He is Head of “Tuberculosis Research” in the School of Chemistry and Molecular Biosciences, University of Queensland. Nick has a particular interest in drug development for TB. His research utilises modern molecular technologies to identify the genetic requirements for Mycobacterium tuberculosis to cause Tuberculosis (TB) with these genetic discoveries translated into novel antibiotic therapies. Research within his group falls largely into one of the following four themes: Essential Gene Identification in M. tuberculosis, Understanding TB Latency, Targeted TB Drug Development and Improving TB Vaccination.

Nick conducted postdoctoral research at the University of Oxford and Imperial College London. Returning to Australia in 2004, he spent several years at Sydney’s Centenary Institute as an Associate Faculty member before relocating to University of Queensland in 2012. In addition to drug development, Nick’s research portfolio includes programmes of vaccine and diagnostic development and testing.

Availability

Associate Professor Nick West is:
Available for supervision
Media expert

Fields of research

Biomedical and Clinical Sciences Medical microbiology

Qualifications

  • Doctor of Philosophy, University of Wollongong

Search Professor Nick West’s works on UQ eSpace

76 works between 1997 and 2024
All (76) Journal Article (74) Book Chapter (1) Conference Publication (1)

61 - 76 of 76 works

2011

Journal Article

Synthesis and Evaluation of Potent Ene-yne Inhibitors of Type II Dehydroquinases as Tuberculosis Drug Leads

Anh Thu Tran, Cergol, Katie M., West, Nicholas P., Randall, Elizabeth J., Britton, Warwick J., Bokhari, Syed Ali Imran, Ibrahim, Musadiq, Lapthorn, Adrian J. and Payne, Richard J. (2011). Synthesis and Evaluation of Potent Ene-yne Inhibitors of Type II Dehydroquinases as Tuberculosis Drug Leads. Chemmedchem, 6 (2), 262-265. doi: 10.1002/cmdc.201000399

Synthesis and Evaluation of Potent Ene-yne Inhibitors of Type II Dehydroquinases as Tuberculosis Drug Leads

2011

Journal Article

Immunity to mycobacterium tuberculosis

Triccas, James A., Winter, Nathalie, Feng, Carl G. and West, Nicholas P. (2011). Immunity to mycobacterium tuberculosis. Clinical & Developmental Immunology, 2011 (406549) 406549, 1-2. doi: 10.1155/2011/406549

Immunity to mycobacterium tuberculosis

2011

Journal Article

Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads

West, Nicholas P., Cergol, Katie M., Xue, Millie, Randall, Elizabeth J., Britton, Warwick J. and Payne, Richard J. (2011). Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads. Chemical Communications, 47 (18), 5166-5168. doi: 10.1039/c0cc05635a

Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads

2010

Journal Article

Tetrahydrolipstatin Inhibition, Functional Analyses, and Three-dimensional Structure of a Lipase Essential for Mycobacterial Viability

Crellin, Paul K., Vivian, Julian P., Scoble, Judith, Chow, Frances M., West, Nicholas P., Brammananth, Rajini, Proellocks, Nicholas I., Shahine, Adam, Le Nours, Jerome, Wilce, Matthew C. J., Britton, Warwick J., Coppel, Ross L., Rossjohn, Jamie and Beddoe, Travis (2010). Tetrahydrolipstatin Inhibition, Functional Analyses, and Three-dimensional Structure of a Lipase Essential for Mycobacterial Viability. Journal of Biological Chemistry, 285 (39), 30050-30060. doi: 10.1074/jbc.M110.150094

Tetrahydrolipstatin Inhibition, Functional Analyses, and Three-dimensional Structure of a Lipase Essential for Mycobacterial Viability

2010

Journal Article

Modulation of Shigella virulence in response to available oxygen in vivo

Marteyn, Benoit, West, Nicholas P., Browning, Douglas F., Cole, Jeffery A., Shaw, Jonathan G., Palm, Fredrik, Mounier, Joelle, Prevost, Marie-Christine, Sansonetti, Philippe and Tang, Christoph M. (2010). Modulation of Shigella virulence in response to available oxygen in vivo. Nature, 465 (7296), 355-358+2. doi: 10.1038/nature08970

Modulation of Shigella virulence in response to available oxygen in vivo

2010

Journal Article

Cutinase-like protein-6 of Mycobacterium tuberculosis is recognised in tuberculosis patients and protects mice against pulmonary infection as a single and fusion protein vaccine

Shanahan, Erin R., Pinto, Rachel, Triccas, James A., Britton, Warwick J. and West, Nicholas P. (2010). Cutinase-like protein-6 of Mycobacterium tuberculosis is recognised in tuberculosis patients and protects mice against pulmonary infection as a single and fusion protein vaccine. Vaccine, 28 (5), 1341-1346. doi: 10.1016/j.vaccine.2009.11.010

Cutinase-like protein-6 of Mycobacterium tuberculosis is recognised in tuberculosis patients and protects mice against pulmonary infection as a single and fusion protein vaccine

2009

Journal Article

Cutinase-like proteins of Mycobacterium tuberculosis: characterization of their variable enzymatic functions and active site identification

West, Nicholas P., Chow, Frances M. E., Randall, Elizabeth J., Wu, Jing, Chen, Jian, Ribeiro, Jose M. C. and Britton, Warwick J. (2009). Cutinase-like proteins of Mycobacterium tuberculosis: characterization of their variable enzymatic functions and active site identification. Faseb Journal, 23 (6), 1694-1704. doi: 10.1096/fj.08-114421

Cutinase-like proteins of Mycobacterium tuberculosis: characterization of their variable enzymatic functions and active site identification

2008

Journal Article

Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis

West, Nicholas P., Wozniak, Teresa M., Valenzuela, Jesus, Feng, Carl G., Sher, Alan, Ribeiro, Jose M. C. and Britton, Warwick J. (2008). Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis. Vaccine, 26 (31), 3853-3859. doi: 10.1016/j.vaccine.2008.05.007

Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis

2005

Journal Article

Available carbon source influences the resistance of Neisseria meningitidis against complement

Exley, RM, Shaw, J, Mowe, E, Sun, YH, West, NP, Williamson, M, Botto, M, Smith, H and Tang, CM (2005). Available carbon source influences the resistance of Neisseria meningitidis against complement. Journal of Experimental Medicine, 201 (10), 1637-1645. doi: 10.1084/jem.20041548

Available carbon source influences the resistance of Neisseria meningitidis against complement

2005

Journal Article

Optimization of virulence functions through glucosylation of Shigella LPS

West, NP, Sansonetti, P, Mounier, J, Exley, RM, Parsot, C, Guadagnini, S, Prevost, MC, Prochnicka-Chalufour, A, Delepierre, M, Tanguy, M and Tang, CM (2005). Optimization of virulence functions through glucosylation of Shigella LPS. Science, 307 (5713), 1313-1317. doi: 10.1126/science.1108472

Optimization of virulence functions through glucosylation of Shigella LPS

2003

Journal Article

Finding your niche: what has been learnt from STM studies on GI colonization

West, NP, Sansonetti, PJ, Frankel, G and Tang, CM (2003). Finding your niche: what has been learnt from STM studies on GI colonization. Trends in Microbiology, 11 (7), 338-344. doi: 10.1016/S0966-842X(03)00154-9

Finding your niche: what has been learnt from STM studies on GI colonization

2003

Journal Article

An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection

McArthur, JD, West, NP, Cole, JN, Jungnitz, H, Guzman, CA, Chin, J, Lehrbach, PR, Djordjevic, SP and Walker, MJ (2003). An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection. Fems Microbiology Letters, 221 (1), 7-16. doi: 10.1016/S0378-1097(03)00162-9

An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection

2002

Journal Article

High throughput in vivo screens: Signature-tagged mutagenesis

West, N, Sansonetti, P and Tang, CM (2002). High throughput in vivo screens: Signature-tagged mutagenesis. Functional Microbial Genomics, 33, 153-165.

High throughput in vivo screens: Signature-tagged mutagenesis

2000

Journal Article

Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence

West, Nicholas P., Jungnitz, Heidrun, Fitter, John T., McArthur, Jason D., Guzman, Carlos A. and Walker, Mark J. (2000). Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infection and Immunity, 68 (8), 4673-4680. doi: 10.1128/IAI.68.8.4673-4680.2000

Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence

1998

Journal Article

A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence

Jungnitz, Heidrun, West, Nicholas P., Walker, Mark J., Chhatwal, Gursharan S. and Guzman, Carlos A. (1998). A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence. Infection and Immunity, 66 (10), 4640-4650.

A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence

1997

Journal Article

Non-motile mini-transposon mutants of Bordetella bronchiseptica exhibit altered abilities to invade and survive in eukaryotic cells

West, NP, Fitter, JT, Jakubzik, U, Rodhe, M, Guzman, CA and Walker, MJ (1997). Non-motile mini-transposon mutants of Bordetella bronchiseptica exhibit altered abilities to invade and survive in eukaryotic cells. Fems Microbiology Letters, 146 (2), 263-269. doi: 10.1111/j.1574-6968.1997.tb10203.x

Non-motile mini-transposon mutants of Bordetella bronchiseptica exhibit altered abilities to invade and survive in eukaryotic cells

Current funding

  • 2023 - 2027
    A Faster Cure for Tuberculosis: Revealing Adjunctive Antimicrobial Solutions
    NHMRC IDEAS Grants
    Open grant
  • 2021 - 2024
    Mycobacterial Cholesterol Degradation: A Unique Metabolic Weakness?
    ARC Discovery Projects
    Open grant

Past funding

  • 2019 - 2023
    Blocking TB Latency: The Key to Reducing Therapy Duration
    NHMRC Project Grant
    Open grant
  • 2018
    Epifluorescent and live-cell imaging microscopes for the investigation of host-pathogen interactions and for molecular and cellular biology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2021
    Ketol-acid reductoisomerase: An important antituberculosis drug target
    NHMRC Project Grant
    Open grant
  • 2018 - 2021
    Killing infected cells as a mechanism to eradicate tuberculosis (NHMRC Project Grant led by The Walter and Eliza Hall Institute of Medical Research)
    Walter & Eliza Hall Institute of Medical Research (WEHI)
    Open grant
  • 2018 - 2020
    Novel TB Drug Candidates via the Inhibition of Lipid I Biosynthesis (NHMRC Project Grant led by University of Sydney)
    University of Sydney
    Open grant
  • 2018 - 2020
    Preventing the evolution of transmissible nitroimidazole resistance in Mycobacterium tuberculosis (NHMRC Project Grant led by Australian National University)
    Australian National University
    Open grant
  • 2016
    Instrumentation for the analysis of cellular and metabolic phenotypes
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2017
    Uncovering Nutrient Acquisition and Metabolism in Mycobacterium tuberculosis (Wellcome Trust grant administered by the Francis Crick Institute)
    Open grant
  • 2015 - 2017
    A new class of inhibitors for the treatment of tuberculosis (NHMRC Project Grant administered by The University of Sydney)
    University of Sydney
    Open grant
  • 2015
    A sensitive, high resolution QTOF mass spectrometer with nanoUPLC system for qualitative and quantitative biomolecule analysis.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2017
    Discovery of new tuberculosis drug leads targeting cell wall biosynthesis (NHMRC Project Grant administered by University of Sydney)
    University of Sydney
    Open grant
  • 2014 - 2016
    Latent Vaccine Development as Directed by in vivo Modeling
    Centenary Institute
    Open grant
  • 2014
    A confocal microscope for investigation of live bacterial and viral pathogens and for molecular cell biology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013
    Facility of Tuberculosis Research
    NHMRC Equipment Grant
    Open grant
  • 2013 - 2016
    Genes of Mycobacterium tuberculosis essential for Latent Tuberculosis Infection
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    Improving subunit vaccines against tuberculosis for pulmonary delivery (NHMRC Project Grant administered by University of Sydney)
    University of Sydney
    Open grant
  • 2013 - 2015
    Potent antibiotics against drug-resistant Tuberculosis
    NHMRC Development Grant
    Open grant
  • 2012 - 2013
    Towards new drugs to treat TB
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2012 - 2014
    Design, development and analysis of new tuberculosis drugs
    NHMRC Project Grant
    Open grant
  • 2012 - 2014
    NHMRC Career Development Fellowship (Biomedical Level 2): Determining the bacterial contributions to tuberculosis and identification of drug targets
    NHMRC Career Development Award
    Open grant

Availability

Associate Professor Nick West is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    A Multidisciplinary Approach to Identifying Novel Vaccine and Drug Targets of Non-Tuberculous Mycobacteria

    Principal Advisor

    Other advisors: Dr Brian Forde

  • Doctor Philosophy

    Boosting BCG: The use of Potent Immunostimulatory Secreted Antigens of Mycobacterium tuberculosis.

    Principal Advisor

    Other advisors: Dr Emily Strong

  • Doctor Philosophy

    Advanced Genetic Toolkit for Cryptococcus neoformans: Iterating Upon Currently Used Techniques in the WHO¿s Top-Ranked Fungal Pathogen

    Associate Advisor

    Other advisors: Professor James Fraser

Completed supervision

Enquiries

Contact Associate Professor Nick West directly for media enquiries about:

  • TB Drug Development
  • TB Vaccine Development
  • Tuberculosis (TB)

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au